Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-29

Clinical Trial Update: Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment

View source ↗

Summary

Clinical trial update describing subanalyses of elderly type 2 diabetes patients or those with renal impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Status: COMPLETED